New study tests CT volume as a tool to track liver cancer treatment success
NCT ID NCT07183566
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study will enroll 66 adults with liver cancer (hepatocellular carcinoma) who are scheduled for either transarterial chemoembolization (TACE) or microwave ablation (MWA). Researchers will use CT scans to measure tumor volume before and after treatment to see if this method can better assess how well the therapy worked. The goal is to improve how doctors evaluate treatment response, not to test a new treatment itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.